398 related articles for article (PubMed ID: 17928600)
1. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis.
Lindor K
N Engl J Med; 2007 Oct; 357(15):1524-9. PubMed ID: 17928600
[No Abstract] [Full Text] [Related]
2. Safe use of ursodeoxycholic acid in a breast-feeding patient with primary biliary cirrhosis.
Vítek L; Zelenková M; Brůha R
Dig Liver Dis; 2010 Dec; 42(12):911-2. PubMed ID: 20619755
[No Abstract] [Full Text] [Related]
3. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
[TBL] [Abstract][Full Text] [Related]
4. Eosinophils and primary biliary cirrhosis-stoking the fire?
Neuberger J
Hepatology; 1999 Jul; 30(1):335-7. PubMed ID: 10385676
[No Abstract] [Full Text] [Related]
5. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid and long-term survival in primary biliary cirrhosis.
Levy C; Angulo P
Am J Gastroenterol; 2004 Feb; 99(2):269-70. PubMed ID: 15046216
[No Abstract] [Full Text] [Related]
8. The long-term beneficial effects of ursodeoxycholic acid in primary biliary cirrhosis are highly questionable.
Yan G; Erik C; Gluud C
Am J Gastroenterol; 2007 Feb; 102(2):464-5. PubMed ID: 17311669
[No Abstract] [Full Text] [Related]
9. Practice variation in treatment of primary biliary cirrhosis and effect on clinical outcomes.
Talwalkar JA; Gossard AA
Hepatology; 2008 Apr; 47(4):1428. PubMed ID: 18366110
[No Abstract] [Full Text] [Related]
10. [Primary biliary cirrhosis and ursodeoxycholic acid therapy].
Makino I
Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):399-403. PubMed ID: 8691003
[No Abstract] [Full Text] [Related]
11. Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past--issues for the future.
Poupon RE
J Hepatol; 2000 Apr; 32(4):685-8. PubMed ID: 10782919
[No Abstract] [Full Text] [Related]
12. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis.
Corpechot C; Poujol-Robert A; Wendum D; Galotte M; Chrétien Y; Poupon RE; Poupon R
Liver Int; 2004 Jun; 24(3):187-93. PubMed ID: 15189267
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis.
Poupon R; Chrétien Y; Chazouillères O; Poupon RE
J Hepatol; 2005 Mar; 42(3):418-9. PubMed ID: 15710226
[No Abstract] [Full Text] [Related]
14. Ursodeoxycholic acid: a second look. Primary biliary cirrhosis: dashed hopes.
Prescrire Int; 2002 Jun; 11(59):67-9. PubMed ID: 12068838
[TBL] [Abstract][Full Text] [Related]
15. Geotherapeutics of primary biliary cirrhosis: bright and sunny around the Mediterranean but still cloudy and foggy in the United Kingdom.
Corpechot C; Poupon R
Hepatology; 2007 Oct; 46(4):963-5. PubMed ID: 17894325
[No Abstract] [Full Text] [Related]
16. Patients and patience: the pitfalls of primary biliary cirrhosis trials.
Mayo MJ
Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):552-3. PubMed ID: 16327817
[No Abstract] [Full Text] [Related]
17. Primary biliary cirrhosis.
Gong Y; Christensen E; Gluud C
N Engl J Med; 2005 Dec; 353(25):2719-20; author reply 2719-20. PubMed ID: 16379089
[No Abstract] [Full Text] [Related]
18. Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid.
Treiber G; Malfertheiner P
J Clin Gastroenterol; 2005 Oct; 39(9):837-8; author reply 838. PubMed ID: 16145353
[No Abstract] [Full Text] [Related]
19. The long-term effect of ursodeoxycholic acid on laboratory liver parameters in biochemically non-advanced primary biliary cirrhosis.
Kuiper EM; Hansen BE; Lesterhuis W; Robijn RJ; Thijs JC; Engels LG; Koek GH; Aparicio MN; Kerbert-Dreteler MJ; van Buuren HR;
Clin Res Hepatol Gastroenterol; 2011 Jan; 35(1):29-33. PubMed ID: 20810227
[TBL] [Abstract][Full Text] [Related]
20. Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid.
Levy C; Peter JA; Nelson DR; Keach J; Petz J; Cabrera R; Clark V; Firpi RJ; Morelli G; Soldevila-Pico C; Lindor K
Aliment Pharmacol Ther; 2011 Jan; 33(2):235-42. PubMed ID: 21083674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
